The effect of enalapril on proteinuria in patients with chronic glomerulonephritis and renal insufficiency.
We evaluated the effect of enalapril on proteinuria in 20 patients with chronic glomerulonephritis (CGN) and renal insufficiency. Patients were accepted into the study according to the following criteria: 1) a serum creatinine (s-Cr) level over 1.5 mg/dl or a creatinine clearance (Ccr) under 70 ml/min; and 2) urinary protein (UP) over 1.0 g/day, expect for the cases with uncontrollable hypertension. We measured total protein (TP), albumin, s-Cr, Ccr, UP, and Ht during the elanapril therapy. After enalapril therapy, UP slowly decreased, and TP and albumin levels increased. The levels of s-Cr and Ccr did not vary. None of the patients required discontinuation of enalapril therapy caused by side effects, such as anemia or hyperkalemia. In conclusion, enalapril has the effect of decreasing in proteinuria and increasing TP and albumin in patients with CGN and renal insufficiency irrespective of the original diseases.
Yoshida
A
A
Division of Nephrology, Nagoya Daini Red Cross Hospital, Japan.
Morozumi
K
K
Takeda
A
A
Koyama
K
K
Ideura
T
T
Ikeda
M
M
Oikawa
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000188:drug therapy*; D051437:Renal Insufficiency / Q000150:complications*
D004656:Enalapril